3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Letrozole
34
Fulvestrant
31
Specimen Handling
29
ribociclib
22
pembrolizumab
22
Paclitaxel
21
Magnetic Resonance Spectroscopy
20
palbociclib
19
Trastuzumab
19
Anastrozole
19
Carboplatin
18
Capecitabine
18
exemestane
17
abemaciclib
16
Biopsy
16
Tamoxifen
15
pertuzumab
14
trastuzumab deruxtecan
12
Cyclophosphamide
10
Taxes
9
Radiotherapy
8
Goserelin
8
Docetaxel
8
giredestrant
7
Standard of Care
7
130-nm albumin-bound paclitaxel
7
inavolisib
6
eribulin
6
elacestrant
6
atezolizumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radionuclide Imaging
×
Breast
×
30 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled